Cargando…
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
BACKGROUND: Tumor-associated (TA) autoantibodies, which are generated by the immune system upon the recognition of abnormal TA antigens, are promising biomarkers for the early detection of tumors. In order to detect autoantibody biomarkers effectively, antibody-specific epitopes in the diagnostic te...
Autores principales: | Hwang, Hai-Min, Heo, Chang-Kyu, Lee, Hye Jung, Kwak, Sang-Seob, Lim, Won-Hee, Yoo, Jong-Shin, Yu, Dae-Yuel, Lim, Kook Jin, Kim, Jeong-Yoon, Cho, Eun-Wie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025833/ https://www.ncbi.nlm.nih.gov/pubmed/29954402 http://dx.doi.org/10.1186/s12967-018-1546-z |
Ejemplares similares
-
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2019) -
Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2020) -
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA
por: Heo, Chang-Kyu, et al.
Publicado: (2022) -
Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012) -
SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
por: Shen, Qingyu, et al.
Publicado: (2018)